Largest Biotechnology Companies by Market Cap
The Biotechnology sector has 1,293 publicly listed stocks with a combined market cap of $2.10 Trillion. Eutilex.Co.Ltd leads the sector with a market cap of $23.94 Million. This ranking covers all Biotechnology stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
$2.10 Trillion
Companies Listed
1,293
Largest Company
Eutilex.Co.Ltd
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 901 |
Eutilex.Co.Ltd
KQ:263050 |
$23.94 Million | ₩35.32 Billion | Korea | ₩959.00 | +29.95% | +29.59% | 23.44 Million |
| 902 |
Maat Pharma SA
PA:MAAT |
$23.68 Million | €20.25 Million | France | €1.08 | -57.06% | -62.50% | 1.45 Million |
| 903 |
Longeveron LLC
NASDAQ:LGVN |
$23.60 Million | $23.60 Million | USA | $6.86 | -0.87% | +0.73% | 9.60 Million |
| 904 |
WOOJUNG BIO Inc
KQ:215380 |
$23.50 Million | ₩34.67 Billion | Korea | ₩2080.00 | -2.58% | -3.03% | 801.36K |
| 905 |
Actuate Therapeutics, Inc. Common stock
NASDAQ:ACTU |
$22.86 Million | $22.86 Million | USA | $0.98 | -4.50% | -33.53% | 10.59 Million |
| 906 |
Tvardi Therapeutics, Inc.
NASDAQ:TVRD |
$22.86 Million | $22.86 Million | USA | $1.83 | -2.14% | -2.66% | 3.61 Million |
| 907 |
CESSATECH A/S DK -20
F:8GN |
$22.85 Million | €19.54 Million | Germany | €1.12 | +2.76% | -1.76% | 0.00 |
| 908 |
Xbrane Biopharma AB
ST:XBRANE |
$22.84 Million | Skr212.24 Million | Sweden | Skr10.30 | +0.00% | +0.00% | 683.69K |
| 909 |
FibroBiologics, Inc. Common Stock
NASDAQ:FBLG |
$22.48 Million | $22.48 Million | USA | $1.44 | -7.10% | -20.44% | 7.64 Million |
| 910 |
Resverlogix Corp.
TO:RVX |
$22.41 Million | CA$30.99 Million | Canada | CA$0.09 | +0.00% | -10.00% | 428.33K |
| 911 |
Isofol Medical AB
ST:ISOFOL |
$22.23 Million | Skr206.61 Million | Sweden | Skr0.74 | -0.54% | +0.82% | 11.38 Million |
| 912 |
Kadimastem Ltd
TA:KDST |
$22.18 Million | ILA8.27 Billion | Israel | ILA2794.00 | -1.13% | -8.21% | 478.25K |
| 913 |
Quantum BioPharma Ltd.
NASDAQ:QNTM |
$22.08 Million | $22.08 Million | USA | $3.46 | +8.12% | +12.34% | 7.14 Million |
| 914 |
Vyne Therapeutics Inc
NASDAQ:VYNE |
$22.03 Million | $22.03 Million | USA | $30.45 | +8.56% | +3311.00% | 39.60 Million |
| 915 |
Lantern Pharma Inc
NASDAQ:LTRN |
$21.73 Million | $21.73 Million | USA | $1.70 | -0.58% | -10.76% | 3.56 Million |
| 916 |
Elevation Oncology Inc
NASDAQ:ELEV |
$21.63 Million | $21.63 Million | USA | $0.37 | +0.00% | +0.00% | 4.82 Million |
| 917 |
NanoViricides Inc
NYSE MKT:NNVC |
$21.57 Million | $21.57 Million | USA | $1.64 | +5.81% | -5.75% | 10.62 Million |
| 918 |
Nanogroup SA
WAR:NNG |
$21.38 Million | zł77.68 Million | Poland | zł2.42 | -1.83% | -1.02% | 900.09K |
| 919 |
Jasper Therapeutics Inc
NASDAQ:JSPR |
$21.06 Million | $21.06 Million | USA | $0.63 | -4.09% | -10.21% | 15.04 Million |
| 920 |
Medivir AB
ST:MVIR |
$21.00 Million | Skr195.17 Million | Sweden | Skr1.74 | -1.81% | -8.90% | 50.04 Million |
| 921 |
Mgenplus Co. Ltd.
KQ:032790 |
$20.92 Million | ₩30.87 Billion | Korea | ₩1202.00 | -9.56% | -14.08% | 6.44 Million |
| 922 |
SynCore Biotechnology Co Ltd
TWO:4192 |
$20.88 Million | NT$662.86 Million | Taiwan | NT$18.85 | +3.29% | +1.89% | 343.48K |
| 923 |
Matricelf Ltd
TA:MTLF |
$20.82 Million | ILA7.77 Billion | Israel | ILA265.60 | +1.26% | -11.38% | 3.68 Million |
| 924 |
Gensight Biologics SA
PA:SIGHT |
$20.63 Million | €17.65 Million | France | €0.12 | -0.51% | +10.30% | 56.85 Million |
| 925 |
VACCITECH (SP.ADR)/1
F:2AB |
$20.62 Million | €17.64 Million | Germany | €0.51 | +5.65% | +10.26% | 6.00K |
| 926 |
Atossa Genetics Inc
NASDAQ:ATOS |
$20.41 Million | $20.41 Million | USA | $2.37 | -4.44% | -5.95% | 1.35 Million |
| 927 |
Neuphoria Therapeutics Inc
NASDAQ:NEUP |
$20.27 Million | $20.27 Million | USA | $3.80 | +1.88% | +1.33% | 1.08 Million |
| 928 |
Tscan Therapeutics Inc
NASDAQ:TCRX |
$19.62 Million | $19.62 Million | USA | $0.32 | +4.90% | -18.04% | 23.51 Million |
| 929 |
Palatin Technologies, Inc. Common Stock
NASDAQ:PTN |
$19.47 Million | $19.47 Million | USA | $10.94 | -18.11% | -13.86% | 3.09 Million |
| 930 |
GridAI Technologies Corp.
NASDAQ:GRDX |
$19.24 Million | $19.24 Million | USA | $3.02 | +1.68% | -7.08% | 3.47 Million |
| 931 |
Oxford Nanopore Technologies Ltd
LSE:ONT |
$18.83 Million | GBX154.74 Billion | UK | GBX158.30 | +2.79% | +0.51% | 65.78 Million |
| 932 |
Marker Therapeutics Inc
NASDAQ:MRKR |
$18.67 Million | $18.67 Million | USA | $1.17 | +0.00% | -0.85% | 1.92 Million |
| 933 |
Sensei Biotherapeutics Inc
NASDAQ:SNSE |
$18.59 Million | $18.59 Million | USA | $25.96 | -28.23% | +78.66% | 1.90 Million |
| 934 |
Urteste SA
WAR:URT |
$18.14 Million | zł65.93 Million | Poland | zł43.20 | -1.82% | +1.41% | 18.86K |
| 935 |
Lipocine Inc
NASDAQ:LPCN |
$18.01 Million | $18.01 Million | USA | $2.19 | -1.58% | -10.82% | 691.59K |
| 936 |
Chemomab Therapeutics Ltd DRC
NASDAQ:CMMB |
$17.95 Million | $17.95 Million | USA | $2.45 | -5.04% | -10.26% | 2.29 Million |
| 937 |
Serina Therapeutics Inc
NYSE MKT:SER |
$17.80 Million | $17.80 Million | USA | $1.98 | +4.93% | +15.12% | 1.95 Million |
| 938 |
Genolution Inc.
KQ:225220 |
$17.72 Million | ₩26.14 Billion | Korea | ₩1447.00 | -2.16% | +5.01% | 702.91K |
| 939 |
Genus PLC
LSE:GNS |
$17.37 Million | GBX142.79 Billion | UK | GBX2150.00 | +0.75% | -5.62% | 3.39 Million |
| 940 |
Devonian Health Group Inc
V:GSD |
$17.35 Million | CA$23.98 Million | Canada | CA$8.63 | -4.17% | -4.17% | 66.64K |
| 941 |
Defence Therapeutics Inc.
F:DTC |
$17.21 Million | €14.72 Million | Germany | €0.28 | +1.43% | -9.84% | 956.98K |
| 942 |
Allarity Therapeutics Inc
NASDAQ:ALLR |
$17.16 Million | $17.16 Million | USA | $1.11 | -5.13% | -21.83% | 2.22 Million |
| 943 |
Simris Alg AB (publ)
ST:SIMRIS-B |
$17.00 Million | Skr157.93 Million | Sweden | Skr0.12 | +6.36% | +30.58% | 4.21 Million |
| 944 |
Initiator Pharma A/S
ST:INIT |
$16.87 Million | Skr156.76 Million | Sweden | Skr2.29 | -2.55% | -4.18% | 2.51 Million |
| 945 |
IRLAB Therapeutics AB (publ)
ST:IRLAB-A |
$16.73 Million | Skr155.46 Million | Sweden | Skr1.83 | -2.45% | +6.14% | 33.86 Million |
| 946 |
Biocardia Inc
NASDAQ:BCDA |
$16.65 Million | $16.65 Million | USA | $1.23 | +3.36% | +13.89% | 4.85 Million |
| 947 |
Imugene Ltd
AU:IMU |
$16.56 Million | AU$23.41 Million | Australia | AU$0.05 | -11.32% | -30.88% | 49.70 Million |
| 948 |
Diamyd Medical AB (publ)
ST:DMYD-B |
$16.53 Million | Skr153.60 Million | Sweden | Skr1.01 | -0.20% | -1.93% | 12.57 Million |
| 949 |
Genenta Science SpA ADR
NASDAQ:GNTA |
$16.45 Million | $16.45 Million | USA | $0.70 | -1.69% | -1.63% | 2.38 Million |
| 950 |
PDS Biotechnology Corp
NASDAQ:PDSB |
$16.40 Million | $16.40 Million | USA | $0.59 | +46.65% | +166.05% | 980.04 Million |
| 951 |
Noxopharm Ltd
AU:NOX |
$16.30 Million | AU$23.04 Million | Australia | AU$0.08 | +0.00% | +5.63% | 2.10 Million |
| 952 |
Argenica Therapeutics Ltd
AU:AGN |
$15.91 Million | AU$22.48 Million | Australia | AU$0.18 | +2.94% | +0.00% | 1.57 Million |
| 953 |
COCRYSTAL PHARMA NEW O.N.
F:8CC |
$15.79 Million | €13.51 Million | Germany | €0.98 | -4.85% | +4.26% | 0.00 |
| 954 |
Proteomics International Laboratories Ltd
AU:PIQ |
$15.78 Million | AU$22.30 Million | Australia | AU$0.14 | -3.57% | -10.00% | 2.17 Million |
| 955 |
Daesung Microbiological Labs. Co. Ltd
KQ:036480 |
$15.73 Million | ₩23.22 Billion | Korea | ₩6110.00 | -0.49% | -0.81% | 99.86K |
| 956 |
Hoth Therapeutics Inc
NASDAQ:HOTH |
$15.67 Million | $15.67 Million | USA | $0.82 | -7.93% | -36.49% | 522.03 Million |
| 957 |
Elicera Therapeutics AB
ST:ELIC |
$15.54 Million | Skr144.39 Million | Sweden | Skr2.98 | -0.34% | +5.12% | 8.46 Million |
| 958 |
Dyadic International Inc
NASDAQ:DYAI |
$15.48 Million | $15.48 Million | USA | $0.43 | +0.80% | -17.73% | 4.86 Million |
| 959 |
Citius Pharmaceuticals Inc
NASDAQ:CTXR |
$15.38 Million | $15.38 Million | USA | $0.56 | -2.27% | -4.74% | 13.91 Million |
| 960 |
ABERA BIOSCIENCE AB
F:8WK |
$15.34 Million | €13.12 Million | Germany | €0.64 | -6.43% | -5.04% | 120.00 |
| 961 |
Aelis Farma SA
PA:AELIS |
$15.30 Million | €13.09 Million | France | €0.96 | +1.05% | -5.33% | 423.52K |
| 962 |
CHEMOMAB THERAP. ADR/20
F:2QV0 |
$15.26 Million | €13.05 Million | Germany | €2.94 | +300.00% | +269.81% | 30.70K |
| 963 |
BTC Health Ltd
AU:BTC |
$15.18 Million | AU$21.45 Million | Australia | AU$0.06 | +0.00% | +0.00% | 197.92K |
| 964 |
Pharma Equity Group A/S Cl A
CO:PEG |
$15.17 Million | Dkr96.98 Million | Denmark | Dkr0.08 | -1.25% | -7.06% | 13.59 Million |
| 965 |
Neurosense Therapeutics Ltd
NASDAQ:NRSN |
$15.14 Million | $15.14 Million | USA | $7.03 | +1.88% | +1276.27% | 11.01 Million |
| 966 |
Cocrystal Pharma Inc
NASDAQ:COCP |
$14.89 Million | $14.89 Million | USA | $1.14 | -2.56% | +0.88% | 1.29 Million |
| 967 |
Pluri Inc.
NASDAQ:PLUR |
$14.87 Million | $14.87 Million | USA | $1.24 | +5.08% | -12.68% | 608.05K |
| 968 |
Applied Therapeutics Inc
NASDAQ:APLT |
$14.86 Million | $14.86 Million | USA | $0.10 | +0.00% | +6.96% | 245.46 Million |
| 969 |
PROBIOTIX HEALTH LS-05
F:X90 |
$14.76 Million | €12.62 Million | Germany | €0.09 | +0.00% | +0.00% | 0.00 |
| 970 |
Cerenome, Inc.
NASDAQ:CNSY |
$14.59 Million | $14.59 Million | USA | $2.12 | -2.30% | -23.19% | 1.88 Million |
| 971 |
Zivo Bioscience Inc
NASDAQ:ZIVO |
$14.59 Million | $14.59 Million | USA | $3.52 | -14.27% | -2.36% | 6.79K |
| 972 |
EZZ Life Science Holdings Ltd
AU:EZZ |
$14.48 Million | AU$20.46 Million | Australia | AU$0.44 | -7.45% | -10.31% | 467.43K |
| 973 |
Cyclacel Pharmaceuticals Inc
NASDAQ:CYCC |
$14.25 Million | $14.25 Million | USA | $6.37 | +0.00% | +0.00% | 220.50K |
| 974 |
GENENTA SCIENCE(SP.ADR)/1
F:K5F |
$14.25 Million | €12.18 Million | Germany | €0.52 | +0.00% | +10.17% | 15.96K |
| 975 |
Passage Bio Inc
NASDAQ:PASG |
$14.14 Million | $14.14 Million | USA | $4.77 | -1.85% | +2.58% | 536.64K |
| 976 |
Vyome Holdings, Inc.
NASDAQ:HIND |
$14.11 Million | $14.11 Million | USA | $2.01 | -2.43% | -9.46% | 184.81K |
| 977 |
Neuroscientific Biopharmaceuticals Ltd
AU:NSB |
$13.88 Million | AU$19.62 Million | Australia | AU$0.06 | -4.84% | -3.28% | 5.65 Million |
| 978 |
Lisata Therapeutics Inc.
NASDAQ:LSTA |
$13.88 Million | $13.88 Million | USA | $1.54 | -1.28% | -6.67% | 11.36 Million |
| 979 |
Medifron DBT Co. Ltd
KQ:065650 |
$13.76 Million | ₩20.31 Billion | Korea | ₩1526.00 | -0.91% | -2.55% | 577.11K |
| 980 |
GENFLOW BIOSCIENCES PLC
F:WQ5 |
$13.66 Million | €11.68 Million | Germany | €0.02 | +0.00% | +0.00% | 0.00 |
| 981 |
Biotechnology Assets S.A.
MC:BST |
$13.52 Million | €11.57 Million | Spain | €0.22 | +0.00% | +2.31% | 3.21 Million |
| 982 |
Anebulo Pharmaceuticals Inc
NASDAQ:ANEB |
$13.52 Million | $13.52 Million | USA | $0.33 | -0.15% | -15.00% | 3.90K |
| 983 |
Cadrenal Therapeutics, Inc. Common Stock
NASDAQ:CVKD |
$12.93 Million | $12.93 Million | USA | $5.53 | -5.63% | +14.97% | 1.28 Million |
| 984 |
Algorae Pharmaceuticals Ltd
AU:1AI |
$12.88 Million | AU$18.21 Million | Australia | AU$0.01 | -10.00% | -18.18% | 13.77 Million |
| 985 |
Advicenne
PA:ALDVI |
$12.61 Million | €10.78 Million | France | €0.74 | -12.82% | -20.41% | 3.45 Million |
| 986 |
NextCell Pharma AB
ST:NXTCL |
$12.54 Million | Skr116.52 Million | Sweden | Skr1.05 | -1.13% | -2.24% | 10.17 Million |
| 987 |
BioLineRx Ltd
NASDAQ:BLRX |
$12.22 Million | $12.22 Million | USA | $2.52 | +3.70% | -5.62% | 599.23K |
| 988 |
Neurotech International Ltd
AU:NTI |
$12.12 Million | AU$17.13 Million | Australia | AU$0.01 | +0.00% | +0.00% | 69.53 Million |
| 989 |
SeaStar Medical Holding Corporation
NASDAQ:ICU |
$12.07 Million | $12.07 Million | USA | $3.02 | -1.64% | +1.34% | 1.28 Million |
| 990 |
Tempest Therapeutics Inc
NASDAQ:TPST |
$12.07 Million | $12.07 Million | USA | $0.76 | -3.68% | -26.66% | 13.94 Million |
| 991 |
CEL-SCI Corp
NYSE MKT:CVM |
$12.01 Million | $12.01 Million | USA | $1.42 | -2.07% | +9.23% | 17.92 Million |
| 992 |
Radiopharm Theranostics Limited American Depositary Shares
NASDAQ:RADX |
$11.98 Million | $11.98 Million | USA | $1.52 | -24.38% | -26.92% | 1.52 Million |
| 993 |
NFL Biosciences SAS
PA:ALNFL |
$11.97 Million | €10.24 Million | France | €0.81 | -1.46% | -9.62% | 528.54K |
| 994 |
Xintela AB
ST:XINT |
$11.96 Million | Skr111.13 Million | Sweden | Skr0.16 | -1.25% | -0.94% | 7.31 Million |
| 995 |
Polyrizon Ltd. Ordinary Shares
NASDAQ:PLRZ |
$11.86 Million | $11.86 Million | USA | $11.39 | +0.62% | +1.33% | 2.13 Million |
| 996 |
Phio Pharmaceuticals Corp
NASDAQ:PHIO |
$11.85 Million | $11.85 Million | USA | $1.02 | -0.97% | -5.56% | 4.23 Million |
| 997 |
GT Biopharma Inc
NASDAQ:GTBP |
$11.56 Million | $11.56 Million | USA | $11.63 | +35.08% | +4009.54% | 9.72 Million |
| 998 |
Hookipa Pharma Inc
NASDAQ:HOOK |
$11.47 Million | $11.47 Million | USA | $1.15 | +0.00% | +0.00% | 48.02K |
| 999 |
Kiora Pharmaceuticals Inc
NASDAQ:KPRX |
$11.41 Million | $11.41 Million | USA | $2.60 | -1.89% | +1.96% | 360.74K |
| 1000 |
Active Biotech AB
ST:ACTI |
$11.36 Million | Skr105.57 Million | Sweden | Skr4.01 | -0.50% | -19.17% | 1.40 Million |
| 1001 |
Nanologica AB
ST:NICA |
$11.25 Million | Skr104.55 Million | Sweden | Skr0.32 | -1.24% | -11.67% | 20.00 Million |
| 1002 |
Sirona Biochem Corp
V:SBM |
$11.23 Million | CA$15.53 Million | Canada | CA$0.06 | +0.00% | +0.00% | 0.00 |
| 1003 |
Pasithea Therapeutics Corp
NASDAQ:KTTA |
$11.20 Million | $11.20 Million | USA | $0.50 | -1.96% | -13.79% | 4.72 Million |
| 1004 |
Poxel SA
PA:POXEL |
$11.17 Million | €9.55 Million | France | €0.18 | +0.11% | -7.19% | 8.99 Million |
| 1005 |
Portage Biotech Inc
NASDAQ:PRTG |
$10.71 Million | $10.71 Million | USA | $4.70 | -0.84% | -10.13% | 35.48 Million |
| 1006 |
MetaVia Inc.
NASDAQ:MTVA |
$10.67 Million | $10.67 Million | USA | $1.62 | -2.41% | -10.99% | 2.37 Million |
| 1007 |
Dare Bioscience Inc
NASDAQ:DARE |
$10.63 Million | $10.63 Million | USA | $0.73 | -0.84% | +1.26% | 20.00 Million |
| 1008 |
VistaGen Therapeutics Inc
NASDAQ:VTGN |
$10.48 Million | $10.48 Million | USA | $0.24 | -2.92% | -1.62% | 13.86 Million |
| 1009 |
TME PHARM.CONF.IPO EO 1-
F:0N6A |
$10.44 Million | €8.93 Million | Germany | €0.10 | +2.94% | -13.48% | 486.29K |
| 1010 |
Clal Biotechnology Industries Ltd
TA:CBI |
$10.39 Million | ILA3.87 Billion | Israel | ILA24.70 | +7.39% | +5.11% | 2.87 Million |
| 1011 |
In8bio Inc
NASDAQ:INAB |
$10.35 Million | $10.35 Million | USA | $1.05 | -5.41% | -12.50% | 1.41 Million |
| 1012 |
Theriva Biologics Inc.
NYSE MKT:TOVX |
$10.33 Million | $10.33 Million | USA | $0.23 | -4.46% | -11.03% | 13.54 Million |
| 1013 |
GlycoMimetics Inc
NASDAQ:GLYC |
$10.13 Million | $10.13 Million | USA | $0.16 | +0.00% | +0.00% | 1.07 Million |
| 1014 |
Aspire BioPharma, Inc.
NASDAQ:ASBP |
$10.09 Million | $10.09 Million | USA | $8.20 | -7.45% | -7.55% | 756.68K |
| 1015 |
BioRestorative Therapies Inc
NASDAQ:BRTX |
$10.05 Million | $10.05 Million | USA | $2.64 | -2.22% | +1683.78% | 7.41 Million |
| 1016 |
Alzinova AB
ST:ALZ |
$10.01 Million | Skr93.01 Million | Sweden | Skr0.46 | -1.18% | -48.94% | 52.54 Million |
| 1017 |
Lunai Bioworks Inc.
NASDAQ:LNAI |
$9.93 Million | $9.93 Million | USA | $2.19 | +0.92% | -8.37% | 870.42K |
| 1018 |
Intensity Therapeutics, Inc. Common stock
NASDAQ:INTS |
$9.92 Million | $9.92 Million | USA | $3.81 | -4.27% | -7.07% | 712.71K |
| 1019 |
CalciMedica, Inc. Common Stock
NASDAQ:CALC |
$9.90 Million | $9.90 Million | USA | $1.98 | -1.00% | -8.76% | 6.70 Million |
| 1020 |
Shenzhen CAU Technology Co Ltd
SHE:000004 |
$9.88 Million | CN¥67.51 Million | China | CN¥0.51 | +10.87% | +13.33% | 151.25 Million |
| 1021 |
Cellectar Biosciences Inc
NASDAQ:CLRB |
$9.84 Million | $9.84 Million | USA | $2.32 | +0.43% | -2.11% | 827.70K |
| 1022 |
Orgenesis Inc
NASDAQ:ORGS |
$9.83 Million | $9.83 Million | USA | $1.95 | +0.00% | +0.00% | 2.56K |
| 1023 |
Annexin Pharmaceuticals AB
ST:ANNX |
$9.79 Million | Skr91.01 Million | Sweden | Skr12.70 | -0.78% | -6.62% | 190.48K |
| 1024 |
Opthea Ltd
AU:OPT |
$9.68 Million | AU$13.68 Million | Australia | AU$0.01 | -9.09% | -16.67% | 127.63 Million |
| 1025 |
Pila Pharma AB
ST:PILA |
$9.66 Million | Skr89.77 Million | Sweden | Skr1.97 | -6.87% | +5.08% | 3.50 Million |
| 1026 |
Quoin Pharmaceuticals Ltd DRC
NASDAQ:QNRX |
$9.62 Million | $9.62 Million | USA | $6.88 | +1.33% | +2.08% | 33.00 Million |
| 1027 |
Entero Therapeutics, Inc.
NASDAQ:ENTO |
$9.58 Million | $9.58 Million | USA | $2.85 | -5.32% | -13.11% | 3.88 Million |
| 1028 |
Biovie Inc
NASDAQ:BIVI |
$9.58 Million | $9.58 Million | USA | $1.75 | -14.63% | -12.50% | 251.48 Million |
| 1029 |
Hemostemix Inc
V:HEM |
$9.54 Million | CA$13.19 Million | Canada | CA$0.07 | -6.67% | -6.67% | 555.15K |
| 1030 |
Adaptimmune Therapeutics Plc
NASDAQ:ADAP |
$9.54 Million | $9.54 Million | USA | $0.04 | -29.13% | -50.34% | 2.65 Billion |
| 1031 |
Pharmena S.A.
WAR:PHR |
$9.53 Million | zł34.64 Million | Poland | zł3.11 | -0.64% | -3.42% | 141.28K |
| 1032 |
Zhuhai Sailong Pharmaceutical Co Ltd
SHE:002898 |
$9.53 Million | CN¥65.12 Million | China | CN¥0.37 | -2.63% | +8.82% | 140.79 Million |
| 1033 |
CytoMed Therapeutics Limited Ordinary Shares
NASDAQ:GDTC |
$9.53 Million | $9.53 Million | USA | $0.81 | -5.45% | -6.47% | 429.14K |
| 1034 |
ESSA Pharma Inc
NASDAQ:EPIX |
$9.52 Million | $9.52 Million | USA | $0.20 | -1.85% | +5.34% | 51.93 Million |
| 1035 |
Kala Pharmaceuticals Inc
NASDAQ:KALA |
$9.44 Million | $9.44 Million | USA | $0.51 | -6.10% | +0.08% | 15.23 Million |
| 1036 |
Adial Pharmaceuticals Inc
NASDAQ:ADIL |
$9.43 Million | $9.43 Million | USA | $5.00 | +0.00% | -29.78% | 1.57 Million |
| 1037 |
Ensysce Biosciences Inc
NASDAQ:ENSC |
$9.36 Million | $9.36 Million | USA | $0.48 | -1.23% | +8.58% | 50.58 Million |
| 1038 |
Immuron Ltd
AU:IMC |
$9.15 Million | AU$12.93 Million | Australia | AU$0.04 | -13.73% | -18.52% | 15.56 Million |
| 1039 |
Biovica International AB (publ)
ST:BIOVIC-B |
$9.12 Million | Skr84.79 Million | Sweden | Skr0.31 | +0.00% | -26.84% | 18.23 Million |
| 1040 |
BioLine RX Ltd
TA:BLRX |
$9.10 Million | ILA3.39 Billion | Israel | ILA1.30 | +0.00% | -7.14% | 102.82 Million |
| 1041 |
AEON Biopharma, Inc.
NYSE MKT:AEON |
$9.05 Million | $9.05 Million | USA | $0.78 | -5.38% | -3.00% | 1.85 Million |
| 1042 |
Exicure Inc
NASDAQ:XCUR |
$8.97 Million | $8.97 Million | USA | $1.37 | -2.14% | +6.20% | 1.10 Million |
| 1043 |
Celyad SA
BR:CYAD |
$8.95 Million | €7.66 Million | Belgium | €0.26 | +16.37% | -3.66% | 334.53K |
| 1044 |
Chromocell Therapeutics Corporation
NYSE MKT:CHRO |
$8.90 Million | $8.90 Million | USA | $22.46 | +0.00% | +0.00% | 4.72K |
| 1045 |
Cambium Bio Ltd
AU:CMB |
$8.90 Million | AU$12.57 Million | Australia | AU$0.46 | +0.00% | +0.00% | 156.21K |
| 1046 |
OPTHEA LTD
F:UKJ |
$8.89 Million | €7.61 Million | Germany | €0.01 | +1.75% | -17.14% | 0.00 |
| 1047 |
Skye Bioscience, Inc. Common Stock
NASDAQ:SKYE |
$8.81 Million | $8.81 Million | USA | $1.99 | -2.45% | +8.15% | 17.93 Million |
| 1048 |
XTL Biopharmaceuticals Ltd ADR
NASDAQ:XTLB |
$8.80 Million | $8.80 Million | USA | $2.45 | -2.59% | +2.73% | 282.27K |
| 1049 |
Visgeneer
TWO:4197 |
$8.74 Million | NT$277.36 Million | Taiwan | NT$9.19 | -5.55% | -0.11% | 3.16 Million |
| 1050 |
Brainstorm Cell Therapeutics Inc
NASDAQ:BCLI |
$8.72 Million | $8.72 Million | USA | $1.06 | -1.60% | -0.68% | 559.25K |
Track real-time market capitalization of largest public companies in the Biotechnology industry. Compare marketcap, analyze stock performance, and discover leading biotechnology corporations. View all industries